Tomáš Dolezal, president of the International Society for Pharmacoeconomics and Outcomes (ISPOR) Czech Regional Chapter and director of the Institute of Health Economics and Technology Assessment (iHETA), gives an overview of the missions and goals of these two institutes and the pivotal role of health technology assessment (HTA) in the healthcare decision making process. Whilst analyzing the Czech healthcare ecosystem Dolezal exposes his concerns about the lack of health literacy in the Czech Republic and outlines how the country collaborates with the rest of Europe.
Over the last two years, the Czech Republic has achieved big advances in terms of patient advocacy, and we should influence other CEE countries in this movement
